EUCTR2004-004139-74-DK进行中（未招募）1 期
Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect.(Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) - N/A
eurologisk afdeling F0 个研究点目标入组 12 人开始时间: 2005年3月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Idiopathic Parkinson's Disease (ICD-10: G20.9)
- •2) Age 50-70
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Any current use of tobacco substances containing nicotine.
- •2) Conditions prohibiting MR scan (implanted pacemaker, protheses etc.)
- •3) Brain diseases apart from Parkinson's Disease (Aneurisms, AV-malformations, stroke, cranial trauma, dementia etc.)
- •4) Psychiatric disorders (Schizophrenia, bi-polar mood disorder, depression)
- •5) Other major diseases (heartfailure, arhytmias, infarcts, kidney failure, liver failure, cirrhosis, active hepatitis, portal hypertension etc.)
- •6) Current use of drugs with major influence on CNS (eg. amphetamine, metamphetamine, cocaine, opioids, antipsychotics, antiepileptics, NMDA-antagonists)
- •7) Current use of the anti-parkinsonian drugs Cabergolin and Amantadine.
- •8) Pregnancy
研究者
相似试验
招募中
不适用
Profiling Parkinson’s diseaseParkinson's diseaseNL-OMON21445Amsterdam UMC, location VUmc1,515
撤回
不适用
The role of imaging in Parkinson*s disease subtypes: a pilot study .NL-OMON35081eids Universitair Medisch Centrum10
Unknown
不适用
Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic CharacteristicsParkinson DiseaseNCT01089283Tel-Aviv Sourasky Medical Center80
招募中
不适用
Profiling Parkinson's diseaseParkinson's diseaseNL-OMON54513Vrije Universiteit Medisch Centrum1,515
已完成
不适用
Establishing 18F PMPBB3 (APN 1607) PET Imaging Markers for Diagnosis of Tauopathy Parkinsonism SyndromesTau Distributions in Patients With Tauopathy Using APN-1607 PET ScanNCT04557865National Taiwan University Hospital68